Eli Lilly's rheumatoid arthritis drug helps recovery in COVID-19 patients – Reuters

Eli Lilly’s rheumatoid arthritis drug helps recovery in COVID-19 patients – Reuters

Eli Lilly and Co said on Monday its rheumatoid arthritis drug baricitinib shortened the time taken to recover from COVID-19 in hospitalized patients when taken in combination with Gilead Sciences Inc’s antiviral remdesivir.

Read More…

You May Also Like